NovaBay Pharmaceuticals to Present at the Virtual Sequire Biotechnology Conference on February 2, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)---- $NBY #Avenova--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that Justin Hall, CEO, will present a company overview at the virtual Sequire Biotechnology Conference on Thursday, February 2 at 2:30 p.m. Eastern time. To register for the event, visit the Sequire Biotechnology website. “We closed 2022 with one of our best quarters ever for Avenova® unit sales. Looking into 2023, we are increasing our focus on our safe, effective wound care products, which we ex

Full Story →